Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-25 @ 4:47 PM
Study NCT ID:
NCT03791060
Status:
TERMINATED
Last Update Posted:
2024-05-17
First Post:
2018-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2018P000634
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |